PDF
Hydromorphone for Opioid Use Disorder
Early results of an Australian clinical trial of parenteral hydromorphone for Opioid Use Disorder.
Session date: May 22, 2024Available downloads
All links are direct pdf downloads of ECHO session presentations unless specified.
Important!
These files are provided for information only and are not intended to replace the clinical judgement of a practitioner. They should not be used alone to guide individual patient care.
Search
Results for "OAT" tag.
Weaning off opioid agonist therapy.
MATOD – A Tasmanian Perspective
Opioid agonist therapy (OAT) and pregnancy.
Opioid agonist therapy (OAT) and pregnancy.
Session date: May 5, 2021
*This presentation contains outdated information and has been removed. Lookout for an update soon*
Session date: May 5, 2021
*This presentation contains outdated information and has been removed. Lookout for an update soon*
Opioids and cognitive impairment
Stigma and OAT
Poly-substance use and OAT
OAT – issues in ongoing management.
PDF
OAT – issues in ongoing management.
Session 4 of our foundation series
Session date: February 10, 2021Opioid use disorder – assessment and treatment
PDF
Opioid use disorder – assessment and treatment
Session 2 of our foundation series
Session date: January 27, 2021